- Home
- FENC vs TMCR Comparison
FENC vs TMCR Comparison
Compare FENC & TMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | TMCR |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.3M | 385.0M |
| IPO Year | 2010 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FENC | TMCR |
|---|---|---|
| Price | $12.30 | $5.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 262.7K | 56.9K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $206.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $4.90 |
| 52 Week High | $13.25 | $8.75 |
Technical Indicators
Market Signals| Indicator | FENC | TMCR |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 45.29 |
| Support Level | $9.74 | $5.32 |
| Resistance Level | N/A | $6.59 |
| Average True Range (ATR) | 0.57 | 0.51 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 71.73 | 48.98 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About TMCR The Metals Royalty Company Inc. Common Stock
The Metals Royalty Co Inc is engaged in the acquisition and management of critical metals and mineral royalties, streams, and other similar interests. It is focused on providing capital to support mineral security and independence in North America in support of accelerating domestic industry growth, including energy, defense, and re-industrialization. The company derives royalty income from its business activities.